Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP,.
• be familiar with best practice in the clinical use of BTM

Endorsement and Accreditation:

Applications for credits points will be submitted to the Swiss Societies for Endocrinology, Internal Medicine, Rheumatology, Physical Medicine and Rehabilitation, Gynecology and Laboratory Medicine as well as the DVO (Dachverband deutschsprachiger osteologischer Gesellschaften). Endorsement will be sought from the Association for Endocrinology, Rheumatology, Clinical Biochemistry and Laboratory Medicine, the Swiss Society against Osteoporosis and the Swiss Bone and Mineral Society and the DVO.

Accomodation:

Hotel Basel
Münzgasse 12
4001 Basel
To receive the special rates, you have to book your rooms no later than 12 August 2019
• Modern Single Room: CHF 210
• Double Single room: CHF 240
*Rates are exclusive of Breakfast and City tax
To book your room contact the hotel directly by e-mail or telephone: +4161 264 68 00 and mention the Booking code: 190911 ECTS

Programme:

Chairman                 Richard Eastell (Sheffield, UK)

08:45-09:30            REGISTRATION AND COFFEE

09:30-09:35            BONE TURNOVER MARKERS: AN INTRODUCTION Richard Eastell (Sheffield, UK)

09:35-10:05            BONE REMODELLING AND THE INTERPRETATION OF BONE TURNOVER MARKER (BTM) RESULTS Richard Eastell (Sheffield, UK)

10:05-10:35            PRACTICAL ASPECTS OF MEASUREMENT AND SELECTION OF MARKER Marius Kraenzlin (Basel, CH)

10:35-11:05            SOURCES OF VARIABILITY IN BTM Christian Meier (Basel, CH)

 11:05-11:30            COFFEE BREAK

 11:30-12:00          USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE Jennie Walsh (Sheffield, UK)

12:00-13:00          INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christan Meier (Basel, CH)

GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION
Marius Kraenzlin (Basel, CH), Richard Eastell (Sheffield, UK)

13:00-13:40            LUNCH

13:40-14:40            METABOLIC BONE DISEASES IN ADULTS Eugene McCloskey (Sheffield, UK)

14:40-15:30            METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDER Barbara Obermayer-Pietsch (Graz, A)

15:30-15:50            COFFEE BREAK

15:50-16:50            INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christian Meier (Basel, CH)  

GROUP C: USING BTM IN METABOLIC BONE DISEASE
Barbara Obermayer-Pietsch (Graz, A), Eugene McCloskey (Sheffield, UK)

 17:10-17:30            EXPERT PANEL: QUESTIONS AND ANSWERS All speakers

 17:30                      CLOSE OF DAY

Our Sponsors:

We thank our sponsors for their support.  The event was supported by the following companies on the form of a sponsorship.  The scientific programme has not been influenced in any way by its sponsors.